Literature DB >> 34280550

Risk Difference of Liver-Related and Cardiovascular Events by Liver Fibrosis Status in Nonalcoholic Fatty Liver Disease.

Nobuharu Tamaki1, Mayu Higuchi2, Masayuki Kurosaki2, Rohit Loomba3, Namiki Izumi4.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) has affected more than one-fourth of the global population, thus emerging as a worldwide health and economic burden.1 The common causes of death in patients with NAFLD include cardiovascular disease (CVD), decompensation, and hepatocellular carcinoma (HCC). However, identifying the risk of these complications in patients with NAFLD remains an unmet need in clinical practice.
Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2021        PMID： 34280550      PMCID： PMC8761224          DOI： 10.1016/j.cgh.2021.07.021

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   13.576


  9 in total

Review 1.  Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.

Authors:  Leon A Adams; Quentin M Anstee; Herbert Tilg; Giovanni Targher
Journal:  Gut       Date:  2017-03-17       Impact factor: 23.059

Review 2.  Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis.

Authors:  Parambir S Dulai; Siddharth Singh; Janki Patel; Meera Soni; Larry J Prokop; Zobair Younossi; Giada Sebastiani; Mattias Ekstedt; Hannes Hagstrom; Patrik Nasr; Per Stal; Vincent Wai-Sun Wong; Stergios Kechagias; Rolf Hultcrantz; Rohit Loomba
Journal:  Hepatology       Date:  2017-03-31       Impact factor: 17.425

Review 3.  Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.

Authors:  Zobair Younossi; Quentin M Anstee; Milena Marietti; Timothy Hardy; Linda Henry; Mohammed Eslam; Jacob George; Elisabetta Bugianesi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-09-20       Impact factor: 46.802

4.  Magnetic Resonance vs Transient Elastography Analysis of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Pooled Analysis of Individual Participants.

Authors:  Cynthia Hsu; Cyrielle Caussy; Kento Imajo; Jun Chen; Siddharth Singh; Kellee Kaulback; Minh-Da Le; Jonathan Hooker; Xin Tu; Ricki Bettencourt; Meng Yin; Claude B Sirlin; Richard L Ehman; Atsushi Nakajima; Rohit Loomba
Journal:  Clin Gastroenterol Hepatol       Date:  2018-06-14       Impact factor: 11.382

5.  Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease.

Authors:  Jeong-Hoon Lee; Donghee Kim; Hwa Jung Kim; Chang-Hoon Lee; Jong In Yang; Won Kim; Yoon Jun Kim; Jung-Hwan Yoon; Sang-Heon Cho; Myung-Whun Sung; Hyo-Suk Lee
Journal:  Dig Liver Dis       Date:  2009-09-18       Impact factor: 4.088

6.  Cardiovascular risk factors in non-alcoholic fatty liver disease.

Authors:  Hannes Hagström; Patrik Nasr; Mattias Ekstedt; Ulf Hammar; Per Stål; Johan Askling; Rolf Hultcrantz; Stergios Kechagias
Journal:  Liver Int       Date:  2018-10-17       Impact factor: 5.828

7.  Advanced fibrosis is associated with incident cardiovascular disease in patients with non-alcoholic fatty liver disease.

Authors:  Jacqueline B Henson; Tracey G Simon; Alyson Kaplan; Stephanie Osganian; Ricard Masia; Kathleen E Corey
Journal:  Aliment Pharmacol Ther       Date:  2020-02-11       Impact factor: 8.171

Review 8.  Sex and gender: modifiers of health, disease, and medicine.

Authors:  Franck Mauvais-Jarvis; Noel Bairey Merz; Peter J Barnes; Roberta D Brinton; Juan-Jesus Carrero; Dawn L DeMeo; Geert J De Vries; C Neill Epperson; Ramaswamy Govindan; Sabra L Klein; Amedeo Lonardo; Pauline M Maki; Louise D McCullough; Vera Regitz-Zagrosek; Judith G Regensteiner; Joshua B Rubin; Kathryn Sandberg; Ayako Suzuki
Journal:  Lancet       Date:  2020-08-22       Impact factor: 79.321

9.  Liver Stiffness by Magnetic Resonance Elastography Predicts Future Cirrhosis, Decompensation, and Death in NAFLD.

Authors:  Tolga Gidener; Omar T Ahmed; Joseph J Larson; Kristin C Mara; Terry M Therneau; Sudhakar K Venkatesh; Richard L Ehman; Meng Yin; Alina M Allen
Journal:  Clin Gastroenterol Hepatol       Date:  2020-09-30       Impact factor: 13.576
  9 in total
  2 in total

1.  Prognostic utility of magnetic resonance elastography and MEFIB index in predicting liver-related outcomes and mortality in individuals at risk of and with nonalcoholic fatty liver disease.

Authors:  Veeral Ajmera; Khang Nguyen; Nobuharu Tamaki; Suzanne Sharpton; Ricki Bettencourt; Rohit Loomba
Journal:  Therap Adv Gastroenterol       Date:  2022-04-29       Impact factor: 4.802

Review 2.  Current therapies and new developments in NASH.

Authors:  Jean-François Dufour; Quentin M Anstee; Elisabetta Bugianesi; Stephen Harrison; Rohit Loomba; Valerie Paradis; Herbert Tilg; Vincent Wai-Sun Wong; Shira Zelber-Sagi
Journal:  Gut       Date:  2022-06-16       Impact factor: 31.793
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.